Cost effective & Value-based Evidence Development
Abstract: One of the more significant barriers to obtaining coverage and reimbursement for a new or established advanced diagnostic is the high cost of the evidence development establishing clinical relevance. Creative approaches and a multi-prong strategy are critical to successfully balance evidence development with budget limitations and internal/investor pressure to broadly launch commercially.
Topics presented to include:
- Clearly defining and staying within intended use
- From study to publication – value-based utility vs. traditional studies vs. value-based contracting
- Advocacy through KOLs & relevant societies
- Relevant patient-level appeals